Mitochondria boosting therapy rejuvenates immune system of mice
Longevity Technology - 11-Oct-2022If successful in humans it would improve the outcome of many age-related diseases
Tom Benson
Founder and CEO of Mitrix.Bio
Tom Benson is the CEO of Mitrix.Bio. Benson launched 2 companies and is the executive of Timepoint Capital.
He was also a manager at the Linac Coherent Light Source (LCLS) facility at Stanford Linear Accelerator National Laboratory, where he gained interest in the imaging of mitochondria via x-ray crystallography and Cryo-EM. This work led him to explore the recent fundamental changes in scientific understanding of cellular energetics and mitochondrial systems of the body.
Visit website: https://www.mitrix.bio/tom-benson.html
See also
Details last updated 29-Jan-2021
Tom Benson News
Mitochondrial transplants show efficacy in achieving longevity in humans
Lifespan.io (LEAF) - 19-Jul-2022Mitochondrial transplant raise energetics of the body, so it can withstand longevity treatments
Mitlets improve immunity and treat many age-related diseases
Longevity Technology - 22-Oct-2021Experimental therapy to transfuse healthy mitochondria from multiple donors
Mitrix gains funding to transfuse young mitochondria
Longevity Technology - 28-Jan-2021Trials on mitochondrial transfusion might help tackle many ageing diseases
Tom Benson is also referenced in the following:
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
